Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

a Prospective, Multi-center, Open-label, Non-inferiority, Randomized, Controlled Registration Trial of the Liquid Embolic Agent for the Treatment of Brain Arteriovenous Malformation

NCT07314047 is registered in ClinicalTrials.gov with MicroPort NeuroTech Co., Ltd. as lead sponsor.

NCT NCT07314047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07314047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
a Prospective, Multi-center, Open-label, Non-inferiority, Randomized, Controlled Registration Trial of the Liquid Embolic Agent for the Treatment of Brain Arteriovenous Malformation
Lead sponsor
MicroPort NeuroTech Co., Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
May 28, 2024
Completion date
May 28, 2026
Enrollment
116 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arteriovenous fistula, brain arteriovenous malformation